Oliver Sutcliffe graduated from the University of Liverpool with a BSc (Hons) in Chemical Sciences (1996) and subsequently obtained a PhD in synthetic organic chemistry working on “New Extended Dipolar Systems” under Drs Richard C. Storr and Thomas L. Gilchrist from the same institution. In 1999, he joined Professor Martin R. Bryce’s group at the University of Durham as a postdoctoral fellow investigating the application of enantiopure ferrocene ligands in asymmetric synthesis, before moving to industry and working as a medicinal chemist on the design, development and optimisation of drug molecules for a broad-range of biological targets, including cancer. He moved to the University of Strathclyde in 2006, obtained an MSc in Pharmaceutical Analysis and after a period at the European Directorate for the Quality of Medicines and Healthcare (EDQM) in Strasbourg was appointed as a lecturer in the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS). In January 2012, Dr Sutcliffe joined the staff at Manchester Metropolitan University as a Senior Lecturer in Psychopharmaceutical Chemistry.
Dr Sutcliffe is a Fellow (FRSC) of the Royal Society of Chemistry and has been awarded Chartered Chemist (CChem), Chartered Scientist (CSci) and European Chemist (EurChem) status. In addition to his academic position Dr Sutcliffe is also Director of MANDRAKE (MANchester DRug Analysis & Knowledge Exchange).